Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Monitoring human papillomavirus prevalence in urine samples: a review.

Enerly E, Olofsson C, Nygård M.

Clin Epidemiol. 2013;5:67-79. doi: 10.2147/CLEP.S39799. Epub 2013 Mar 12. Erratum in: Clin Epidemiol. 2013;5:371.

2.

Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.

Daponte A, Pournaras S, Mademtzis I, Hadjichristodoulou C, Kostopoulou E, Maniatis AN, Messinis IE.

J Clin Virol. 2006 Jul;36(3):189-93. Epub 2006 May 11.

PMID:
16690350
3.
4.

Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.

Munoz M, Camargo M, Soto-De Leon SC, Sanchez R, Parra D, Pineda AC, Sussmann O, Perez-Prados A, Patarroyo ME, Patarroyo MA.

PLoS One. 2013;8(2):e56509. doi: 10.1371/journal.pone.0056509. Epub 2013 Feb 13.

5.

Concordance of human papillomavirus in the cervix and urine among inner city adolescents.

Jacobson DL, Womack SD, Peralta L, Zenilman JM, Feroli K, Maehr J, Daniel RW, Shah KV.

Pediatr Infect Dis J. 2000 Aug;19(8):722-8.

PMID:
10959740
6.

Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males.

Bissett SL, Howell-Jones R, Swift C, De Silva N, Biscornet L, Parry JV, Saunders NA, Nathan M, Soldan K, Szarewski A, Cuzick J, Beddows S.

J Med Virol. 2011 Oct;83(10):1744-51. doi: 10.1002/jmv.22167. Erratum in: J Med Virol. 2011 Dec;83(12):2237.

PMID:
21837790
7.

High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.

Tanzi E, Bianchi S, Fasolo MM, Frati ER, Mazza F, Martinelli M, Colzani D, Beretta R, Zappa A, Orlando G.

J Med Virol. 2013 Jan;85(1):91-8. doi: 10.1002/jmv.23434. Epub 2012 Oct 23.

PMID:
23097252
8.

Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.

Stanczuk GA, Kay P, Allan B, Chirara M, Tswana SA, Bergstrom S, Sibanda EN, Williamson AL.

J Med Virol. 2003 Sep;71(1):110-4.

PMID:
12858416
9.

Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women.

Brinkman JA, Jones WE, Gaffga AM, Sanders JA, Chaturvedi AK, Slavinsky III J, Clayton JL, Dumestre J, Hagensee ME.

J Clin Microbiol. 2002 Sep;40(9):3155-61.

10.

Screening for human papillomavirus: is urine useful?

D'Hauwers KW, Tjalma WA.

Indian J Cancer. 2009 Jul-Sep;46(3):190-3. doi: 10.4103/0019-509X.52952. Review.

11.

Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis.

Tricco AC, Ng CH, Gilca V, Anonychuk A, Pham B, Berliner S.

BMC Infect Dis. 2011 Sep 5;11:235. doi: 10.1186/1471-2334-11-235. Review.

12.
13.

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors.

Damm O, Nocon M, Roll S, Vauth C, Willich S, Greiner W.

GMS Health Technol Assess. 2009 Mar 11;5:Doc04. doi: 10.3205/hta000066.

14.

Human papillomavirus infection among young adolescents in India: impact of vaccination.

Hussain S, Bharadwaj M, Nasare V, Kumari M, Sharma S, Hedau S, Das BC.

J Med Virol. 2012 Feb;84(2):298-305. doi: 10.1002/jmv.22261.

PMID:
22170551
15.

Screening for genital human papillomavirus: results from an international validation study on human papillomavirus sampling techniques.

de Sanjosé S, Bosch XF, Muñoz N, Chichareon S, Ngelangel C, Balagueró L, Jacobs MV, Meijer CJ, Walboomers JM.

Diagn Mol Pathol. 1999 Mar;8(1):26-31.

PMID:
10408790
16.

Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chernesky M.

CMAJ. 2000 Sep 5;163(5):513-8.

17.

Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.

Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX, Muñoz N, Palacios S, San Martin Rodriguez M, Serradell L, Torcel-Pagnon L, Cortes J; CLEOPATRE Spain Study Group.

J Med Virol. 2012 Jun;84(6):947-56. doi: 10.1002/jmv.23282.

PMID:
22499018
18.

PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.

Fambrini M, Penna C, Pieralli A, Bussani C, Fallani MG, Andersson KL, Scarselli G, Marchionni M.

Gynecol Oncol. 2008 Apr;109(1):59-64. doi: 10.1016/j.ygyno.2007.12.032. Epub 2008 Feb 5.

PMID:
18255129
19.

Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices.

Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V.

J Obstet Gynaecol. 2009 Oct;29(7):583-9. doi: 10.1080/01443610903061736. Review.

PMID:
19757259
20.

Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign.

Vu LT, Bui D, Le HT.

BMC Cancer. 2013 Feb 4;13:53. doi: 10.1186/1471-2407-13-53.

Supplemental Content

Support Center